Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases

Although dyslipidemia is associated with chronic kidney disease (CKD), it is more common in nephrotic syndrome (NS), and guidelines for the management of hyperlipidemia in NS are largely opinion-based. In addition to the role of circulating lipids, an increasing number of studies suggest that intrar...

Full description

Bibliographic Details
Main Authors: Mengyuan Ge, Sandra Merscher, Alessia Fornoni
Format: Article
Published: MDPI AG 2021-08-01
Series:Journal of Personalized Medicine
Online Access: